Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome
- 8 October 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 114 (15), 3181-3190
- https://doi.org/10.1182/blood-2009-02-205708
Abstract
Gaucher disease causes pathologic skeletal changes that are not fully explained. Considering the important role of mesenchymal stromal cells (MSCs) in bone structural development and maintenance, we analyzed the cellular biochemistry of MSCs from an adult patient with Gaucher disease type 1 (N370S/L444P mutations). Gaucher MSCs possessed a low glucocerebrosidase activity and consequently had a 3-fold increase in cellular glucosylceramide. Gaucher MSCs have a typical MSC marker phenotype, normal osteocytic and adipocytic differentiation, growth, exogenous lactosylceramide trafficking, cholesterol content, lysosomal morphology, and total lysosomal content, and a marked increase in COX-2, prostaglandin E2, interleukin-8, and CCL2 production compared with normal controls. Transcriptome analysis on normal MSCs treated with the glucocerebrosidase inhibitor conduritol B epoxide showed an up-regulation of an array of inflammatory mediators, including CCL2, and other differentially regulated pathways. These cells also showed a decrease in sphingosine-1-phosphate. In conclusion, Gaucher disease MSCs display an altered secretome that could contribute to skeletal disease and immune disease manifestations in a manner distinct and additive to Gaucher macrophages themselves.Keywords
This publication has 54 references indexed in Scilit:
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Lipid composition of microdomains is altered in a cell model of Gaucher diseaseJournal of Lipid Research, 2008
- Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient miceBMC Neuroscience, 2008
- Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff diseaseHuman Molecular Genetics, 2008
- Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literatureAnnals of Hematology, 2008
- Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblastsAging Cell, 2008
- Effects of prostaglandin E2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cellsProstaglandins, Leukotrienes & Essential Fatty Acids, 2007
- Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stressJournal of Cellular Physiology, 2007
- Sterol carrier protein-2: New roles in regulating lipid rafts and signalingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growthHuman Molecular Genetics, 2007